(MMS) Maximus - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US5779331041

MMS: Government, Services, BPO, Technology, Healthcare, Employment

Maximus, Inc. (NYSE:MMS) is a global leader in government services, specializing in business process services (BPS), technology solutions, and program management. The company operates through three core segments: U.S. Federal Services, U.S. Services, and Outside the U.S. Its expertise spans federal health and human services, clinical solutions, advanced analytics, cybersecurity, and digital transformation. Founded in 1975 and headquartered in McLean, Virginia, Maximus has established itself as a trusted partner for governments worldwide, delivering scalable solutions to complex public sector challenges.

The U.S. Federal Services segment provides mission-critical support to federal health and human services programs, including eligibility and enrollment services, application development, and modernization of legacy systems. The U.S. Services segment focuses on state-level programs, offering multilingual customer contact centers, employment services, and technology solutions for Medicaid, CHIP, and other health programs. The Outside the U.S. segment extends these capabilities internationally, delivering health and disability assessments, employment services, and digital customer solutions to governments in the UK, Australia, and other regions.

Maximus combines deep domain expertise with advanced technologies to drive operational efficiency and improve outcomes for government programs. Its services are underpinned by a commitment to innovation, with a focus on emerging technologies such as AI, machine learning, and cloud-based solutions. The company’s extensive experience in managing large-scale government contracts positions it as a key player in the outsourced services market.

Ticker Symbol: MMS Exchange: NYSE Type: Common Stock Country Origin: United States GICS Sub Industry: Data Processing & Outsourced Services Average Volume 20d: 480,250 Last Price: 67.72 SMA 20: 68.16 SMA 50: 67.71 SMA 200: 79.20 ATR: 1.95 Market Cap: $3,812.60M USD P/E: 14.52 P/E Forward: 18.25 P/B: 2.32 P/S: 0.71 RoE: 17.24 3-Month Forecast Based on the provided data, Maximus (MMS) is expected to maintain stable performance in the near term. The stock is trading near its SMA 50 and SMA 20, indicating a potential sideways trend. Support levels are likely to hold around the SMA 50 at 67.71, with resistance near the SMA 20 at 68.16. The ATR of 1.95 suggests moderate volatility, with potential price fluctuations within a narrow range. Fundamental strength, including a strong RoE of 17.24 and a reasonable P/E of 14.52, supports the stock’s valuation. However, the forward P/E of 18.25 indicates expectations of slower earnings growth. Overall, MMS is likely to remain range-bound, with upside limited by broader market conditions and downside protected by its defensive business model.

Additional Sources for MMS Stock

MMS Stock Overview

Market Cap in USD 3,750m
Sector Industrials
Industry Specialty Business Services
GiC Sub-Industry Data Processing & Outsourced Services
IPO / Inception 1997-06-12

MMS Stock Ratings

Growth Rating 0.39
Fundamental 51.4
Dividend Rating 48.9
Rel. Strength -14.7
Analysts 4/5
Fair Price Momentum 70.93 USD
Fair Price DCF 106.40 USD

MMS Dividends

Dividend Yield 12m 1.51%
Yield on Cost 5y 1.88%
Annual Growth 5y 1.39%
Payout Consistency 96.9%

MMS Growth Ratios

Growth Correlation 3m 3%
Growth Correlation 12m -74%
Growth Correlation 5y 29.1%
CAGR 5y 3.46%
CAGR/Max DD 5y 0.09
Sharpe Ratio 12m -0.13
Alpha -14.48
Beta 0.262
Volatility 25.11%
Current Volume 1045k
Average Volume 20d 382.9k
What is the price of MMS stocks?
As of May 09, 2025, the stock is trading at USD 75.74 with a total of 1,044,967 shares traded.
Over the past week, the price has changed by +14.19%, over one month by +15.56%, over three months by +9.15% and over the past year by -8.59%.
Is Maximus a good stock to buy?
Partly, yes. Based on ValueRay Fundamental Analyses, Maximus (NYSE:MMS) is currently (May 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 51.41 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of MMS as of May 2025 is 70.93. This means that MMS is currently overvalued and has a potential downside of -6.35%.
Is MMS a buy, sell or hold?
Maximus has received a consensus analysts rating of 4.00. Therefor, it is recommend to buy MMS.
  • Strong Buy: 0
  • Buy: 2
  • Hold: 0
  • Sell: 0
  • Strong Sell: 0
What are the forecast for MMS stock price target?
According to ValueRays Forecast Model, MMS Maximus will be worth about 76.6 in May 2026. The stock is currently trading at 75.74. This means that the stock has a potential upside of +1.14%.
Issuer Forecast Upside
Wallstreet Target Price 102 34.7%
Analysts Target Price 102 34.7%
ValueRay Target Price 76.6 1.1%